Surgery – Diagnostic testing
Reexamination Certificate
2004-12-02
2009-12-01
Nasser, Robert L (Department: 3735)
Surgery
Diagnostic testing
C600S544000, C600S546000
Reexamination Certificate
active
07625340
ABSTRACT:
The invention seeks to provide a method and a system for identifying a dominant signal component in a biosignal including at least two signal components. A biosignal including a first signal component having a first frequency range and a second signal component having a second frequency range is obtained from a subject. First and second indicators are then determined, which characterize the probability distribution of a predefined property, such as frequency, of the biosignal on predetermined primary and auxiliary frequency bands, respectively. Based on the first and second indicators, the system detects which one of the first and second signal components is currently a dominant signal component in the biosignal. The knowledge of the dominant component may be utilized in different ways in different systems monitoring the state of the subject.
REFERENCES:
patent: 6032072 (2000-02-01), Greenwald
patent: 6338713 (2002-01-01), Chamoun et al.
patent: 7130673 (2006-10-01), Tolvanen-Laakso et al.
patent: 2004/0204656 (2004-10-01), Tolvanen-Laakso et al.
patent: 1 468 646 (2004-10-01), None
European Search Report dated Apr. 11, 2006.
H. Viertiö-Oja et al., “Description of the Entropy algorithm as applied in the Datex-Ohmeda S/5 Entropy Module”, ACTA Anaesthesiol. Scand., vol. 48, Jan. 22, 2004, pp. 154-161.
R. E. Anderson, et al., “Entropy during propofol hypnosis, including an episode of wakefulness”, Anaesthesia, vol. 52, Jan. 2004, pp. 52-56.
Hairong Zheng et al., “Advantages in using multi-frequency driving to enhance ultrasound contrast microbubble non-linearities for optimizing echo particle image velocimetry techniques”, Biomedical Imaging: Macro to Nano, 2004. IEEE International Symposium on Arlington, VA Apr. 15-18, 2004, Piscataway, NJ, Apr. 15, 2004, pp. 500-503.
Roberto Massetani et al., “Alteration of Cardiac Function in Patients with Temporal Lobe Epilepsy: Different Roles of EEG-ECG Monitoring and Spectral Analysis of RR Variability”, Epilepsia, No. 38, Mar. 1997, pp. 363-369.
Hans-Bernd Hopf et al., “Low-frequency Spectral Power of Heart Rate Variability is not a Specific Marker of Cardiac Sympathetic Modulation”, Anesthesiology, vol. 82, No. 3, Mar. 1995, p. 619.
Andrus Sceales Starke & Sawall LLP
Instrumentarium Corporation
Nasser Robert L
LandOfFree
Identification of a dominant signal component in a biosignal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Identification of a dominant signal component in a biosignal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification of a dominant signal component in a biosignal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4125638